Cite

    Ikesue, H. et al. (2020). Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer. Journal of clinical pharmacy and therapeutics. pp. 1288-1294. [Online].